Human TNFRSF4/OX40 ELISA Kit View larger

Human TNFRSF4/OX40 ELISA Kit

FM-E100266

$599.00

$599.00 per 1x96T

More info

Assay Range

31.2-2,000 pg/mL  

Sensitivity

10.0 pg/mL

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Sample Type

serum, plasma or cell culture supernatant 

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Human TNFRSF4  standard: 2 vials

 2. One 96-well plate coated with Human TNFRSF4  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 130 µL, dilution 1:100

 5. Streptavidin-HRP: 130 µL, dilution 1:100

 6. Antibody diluent buffer: 12 mL x1   

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. TMB developing agent: 10 mL x1

 9. Stop solution: 10 mL x1

10. Washing solution (20x): 25 mL x1

 

 

Background

 

OX40, also known as tumor necrosis factor receptor superfamily member 4 (TNFRSF4), or CD134, is a member of the tumor necrosis factor receptor superfamily. Human OX40 is a type I transmembrane glycoprotein composed of a 28 amino acid (aa) signal sequence, a 185 aa extracellular domain (ECD) with four TNFR-cys repeats and an O-glycosylated hinge region, a 20 aa transmembrane segment, and a 41 aa cytoplasmic domain. A naturally occurring soluble OX40 has also been identified in human serum. The ECD of human OX40 shows 67%, 64% and 64% aa identity with rabbit, mouse and rat OX40 ECD, respectively. OX40 is a T cell activation antigen that is expressed primarily on activated CD4+ T cells, but is also expressed on activated human and mouse CD8+ T cells. OX40 is a receptor for OX40 ligand (OX40L)/gp34, a type II transmembrane glycoprotein of the TNF superfamily. Ligation of OX40 on T cells by OX40L or an agonistic antibody can promote clonal expansion, long-term T cell survival, and enhance memory T cell development. It has been showed that blockade of OX40L/OX40 interaction is useful for treating autoimmune disease and graft-versus-host disease in animal models.

Download

© 2024 Novateinbio.com